Treatment of the ischemic stroke has remained a major healthcare challenge. The phenolic compound,
sesamol, has shown promising antioxidant and neuroprotective effects, however, fast clearance may negatively affect
its efficiency. This, prompted us to incorporate sesamol into the nanostructured lipid carriers (S-NLCs) and evaluate its
therapeutic potential in in vitro and in vivo models of ischemic stroke.

EB00000002710K

Available

• Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway